Log in to search using one of your social media accounts:

 

BRCA Breast Cancer Gene Doesn't Affect Survival
BRCA mutations are inherited and increase the risk of breast and ovarian cancers. Between 45 percent and 90 percent of women with a BRCA mutation develop breast cancer, compared with about 12.5 percent of women in the general population. (Source: WebMD Health)
Source: WebMD Health - January 12, 2018 Category: Consumer Health News Source Type: news

FDA Approves First Drug for Tumors Tied to Breast Cancer Genes
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Research, News, Source Type: news

BRCA Breast Cancer Gene Doesn ’ t Affect Patient Survival: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Nursing, Oncology, Research, Surgery, News, Source Type: news

First treatment approved for breast cancer with BRCA genetic mutation
The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer associated with the same mutations. Richard Pazdur, director of the […]Related:FDA warns against giving kids cough and cold medicines with codeine or hydrocodoneNew study on abortion pill shows high success, low rate of complicationsHe was 21 and fit. He tried to push through the flu — and it killed him. (Source: Wash...
Source: Washington Post: To Your Health - January 12, 2018 Category: Consumer Health News Source Type: news

First Drug for BRCA Breast Cancer: Olaparib First Drug for BRCA Breast Cancer: Olaparib
Olaparib has achieved two firsts in breast cancer: it's the first PARP inhibitor and the first drug for patients carrying the BRCA mutation.FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA approves expanded use of AstraZeneca cancer drug
(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc's cancer drug Lynparza to include patients with metastatic breast cancer whose disease is associated with a mutation of the BRCA gene. (Source: Reuters: Health)
Source: Reuters: Health - January 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA approves expanded use of AstraZeneca breast cancer drug
(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc's cancer drug Lynparza to include patients with metastatic breast cancer whose disease is associated with a mutation of the BRCA gene. (Source: Reuters: Health)
Source: Reuters: Health - January 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves first treatment for breast cancer with a certain inherited genetic mutation
(Source: Food and Drug Administration)
Source: Food and Drug Administration - January 12, 2018 Category: American Health Source Type: news

WATCH: Sandra Lee opens up about her breast-cancer journey in new documentary
The "Semi-Homemade" chef shares about her battle with breast cancer in the HBO documentary, "Rx Early Detection: A Cancer Journey with Sandra Lee," premiering at the Sundance Film Festival. (Source: ABC News: Health)
Source: ABC News: Health - January 12, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Lynparza (Olaparib), First Treatment Approved for Breast Cancer Caused by Specific Gene Mutation
FRIDAY, Jan. 12, 2018 -- Lynparza (olaparib) has been approved by the U.S. Food and Drug Administration to treat spreading breast cancer caused by a BRCA gene mutation. The drug is among a class called poly ADP-ribose polymerase (PARP) inhibitors,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 12, 2018 Category: General Medicine Source Type: news

Breast cancer survival 'unaffected by faulty gene'
Young breast cancer patients with faulty BRCA genes have the same survival chances as those without, a study has found. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 12, 2018 Category: Consumer Health News Source Type: news

FDA Approves Lynparza (Olaparib), First Drug for Tumors Tied to Breast Cancer Genes
FRIDAY, Jan. 12, 2018 -- The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation. These mutated genes, called BRCA1 and BRCA2, first came to prominence in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 12, 2018 Category: General Medicine Source Type: news

BRCA Breast Cancer Gene Doesn't Affect Patient Survival: Study
FRIDAY, Jan. 12, 2018 -- Young breast cancer patients with a BRCA gene mutation have the same chances of survival after treatment as those without the mutation, a new study finds. BRCA mutations are inherited and increase the risk of breast and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 12, 2018 Category: General Medicine Source Type: news

FDA approves first treatment for breast cancer with a certain inherited genetic mutation
The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation. (Source: World Pharma News)
Source: World Pharma News - January 12, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Rethinking neoadjuvant chemotherapy for breast cancer
This BMJ analysis notes that neoadjuvant chemotherapy may not be beneficial to patients as increased pathological response of primary tumour does not translate into a survival benefit. It suggests that the widespread use of neoadjuvant chemotherapy should be reduced. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 12, 2018 Category: Consumer Health News Source Type: news

Should chest CT scans be reviewed for breast lesions?
What should be done with incidental breast lesions detected in women receiving...Read more on AuntMinnie.comRelated Reading: Women overestimate breast cancer risk, prefer biopsy AI algorithm matches radiologists in breast screening exams Mammo recalls don't keep women from other tests Most women prefer annual breast cancer screening Breast AI algorithm could reduce unnecessary surgery by 30% (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 12, 2018 Category: Radiology Source Type: news

Cancer caused by BRCA gene less dangerous than thought
The research, led by the University of Southampton, concludes that BRCA-mutated breast cancer is no more dangerous or aggressive than any other form of the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - January 12, 2018 Category: Consumer Health News Source Type: news

Breast cancer gene mutation 'doesn't affect survival'
Research also suggests a double mastectomy may not improve survival for young women diagnosed with breast cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 12, 2018 Category: Consumer Health News Source Type: news

BRCA gene mutation 'doesn't affect breast cancer survival'
Young women with breast cancer have the same survival rates regardless of whether they have the BRCA gene mutation, a study suggests. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 12, 2018 Category: Consumer Health News Source Type: news

First Treatment Approved for Breast Cancer Caused by Specific Gene Mutation
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - January 12, 2018 Category: Cancer & Oncology Source Type: news

Lentils, nuts and cereals reverse breast cancer treatment
Estrogen fuels the growth of common forms of breast cancer. Some treatments work by blocking estrogen, but foods like soy beans reverse their effects, a Scripps University study warns. (Source: the Mail online | Health)
Source: the Mail online | Health - January 11, 2018 Category: Consumer Health News Source Type: news

Lump in this area of the body is a sign of breast cancer (and it’s not the the breast)
BREAST cancer is usually only associated with women, but in rare cases men can get it too. The signs and symptoms to watch out for are very similar, including a lump, swelling or small bumps in either armpit. (Source: Daily Express - Health)
Source: Daily Express - Health - January 11, 2018 Category: Consumer Health News Source Type: news

Lump in this area of the body is a sign of breast cancer (and it’s not the breast)
BREAST cancer is usually only associated with women, but in rare cases men can get it too. The signs and symptoms to watch out for are very similar, including a lump, swelling or small bumps in either armpit. (Source: Daily Express - Health)
Source: Daily Express - Health - January 11, 2018 Category: Consumer Health News Source Type: news

ACR releases appropriateness summaries for patients
The American College of Radiology (ACR) has released the first examples of...Read more on AuntMinnie.comRelated Reading: CMS renews ACR's data registry for 2018 ACR calls for summer radiology internship applications ACR revises Appropriateness Criteria ACR names 2018 gold medalists ACR releases breast cancer screening criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 11, 2018 Category: Radiology Source Type: news

Alcohol Consumption and Breast Tumor Gene Expression Alcohol Consumption and Breast Tumor Gene Expression
Does moderate alcohol intake affect biological processes and pathways associated with breast cancer?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Estrogen-mimicking compounds in foods may reduce effectiveness of breast cancer treatment
(Scripps Research Institute) Scientists from The Scripps Research Institute have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination for treating breast cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 11, 2018 Category: Biology Source Type: news

New Treatments vs Screening in Reducing Breast Cancer Deaths New Treatments vs Screening in Reducing Breast Cancer Deaths
Improvements in breast cancer screening and novel treatments have contributed to breast cancer mortality reductions in recent years, although the impact varies by disease subtype, say US scientists.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Many women uninformed about breast cancer surgery options
(Reuters Health) - - Women with breast cancer often feel rushed to make a decision about surgery, and some of them might benefit from more time and better educational materials to inform their treatment choices, two recent studies suggest. (Source: Reuters: Health)
Source: Reuters: Health - January 10, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

What Risks for Radiation in Scleroderma Patients with Breast Cancer? (CME/CE)
(MedPage Today) -- Acute toxicity and disease flares were rare (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - January 10, 2018 Category: Radiology Source Type: news

Night shift nurses at higher risk of developing common cancers
Female nurses who regularly work nights are significantly more likely to develop breast cancer and other common forms of the disease than those on day shifts, suggests a new study. (Source: Nursing Times)
Source: Nursing Times - January 10, 2018 Category: Nursing Source Type: news

Dissatisfaction With Breasts May Mean Fewer Self-Checks for Cancer
WEDNESDAY, Jan. 10, 2018 -- Women who are unhappy with the size of their breasts -- whether too big or too small -- may be less likely to perform self-exams to check for signs of breast cancer, new research suggests. These women are also more... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 10, 2018 Category: General Medicine Source Type: news

Higher risk of hormone-related cancers in female night shift workers
According to a review, published inCancer Epidemiology Biomarkers& Prevention, female night shift workers in North America and Europe are at greater risk of developing hormone-related cancers, including breast cancer.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 10, 2018 Category: Endocrinology Source Type: news

Screening, Treatment Cuts Breast Cancer Deaths in Half
Title: Screening, Treatment Cuts Breast Cancer Deaths in HalfCategory: Health NewsCreated: 1/9/2018 12:00:00 AMLast Editorial Review: 1/10/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 10, 2018 Category: Cancer & Oncology Source Type: news

New breast cancer test 'could cut out chemo'
Dr Anita Grigoriadis, who led the research at King's College in London has discovered that one quarter of women with cancer in their lymph nodes will not see the disease spread further. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2018 Category: Consumer Health News Source Type: news

Screening, Treatment Cuts Breast Cancer Deaths in Half
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - January 10, 2018 Category: Cancer & Oncology Source Type: news

Research: New screenings, treatments dramatically reduce breast cancer deaths
Breast cancer deaths have dramatically declined as a result of new drugs and better screenings since 2000, six independent groups of researchers have concluded. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 9, 2018 Category: Consumer Health News Source Type: news

Screening, Treatment Cuts Breast Cancer Deaths in Half
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 9, 2018 Category: Cancer & Oncology Tags: Family Medicine, Nursing, Oncology, Radiology, Research, Preventive Medicine, News, Source Type: news

Both screening, treatment cut breast cancer deaths
Which factor -- screening or treatment -- has been behind the sharp reduction...Read more on AuntMinnie.comRelated Reading: What are the risks of risk-based breast cancer screening? Personalized breast cancer screening study launches USPSTF's breast cancer screening recs dampen compliance Most women prefer annual breast cancer screening ACR releases breast cancer screening criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 9, 2018 Category: Radiology Source Type: news

Xcision Receives FDA 510(k) Clearance for the GammaPod Stereotactic Radiotherapy System for Breast Cancer
COLUMBIA, Md., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatme... Devices, Oncology, FDA Xcision Medical Systems, GammaPod, Stereotactic, Radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2018 Category: Pharmaceuticals Source Type: news

Screening, Treatment Cuts Breast Cancer Deaths in Half
TUESDAY, Jan. 9, 2018 -- Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals. " Advances in screening and treatment are saving lives, " said lead researcher Sylvia... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2018 Category: General Medicine Source Type: news

Drug Penetrance of Veliparib and Carboplatin in TNBC Drug Penetrance of Veliparib and Carboplatin in TNBC
Researchers investigate whether non-response to chemotherapy in TNBC is due to insufficient drug penetration.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2018 Category: Consumer Health News Tags: None Journal Article Source Type: news

New treatments, screening methods dramatically reduce breast cancer deaths, study finds
(Stanford University Medical Center) Six groups of researchers, including one from Stanford, collaborated to study the effect of advances in breast cancer screening and treatment on mortality rates. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2018 Category: Cancer & Oncology Source Type: news

Targeting breast cancer through precision medicine
(University of Alberta Faculty of Medicine& Dentistry) University of Alberta researchers have discovered a mechanism that may make cancer cells more susceptible to treatment. The research team found that the protein RYBP prevents DNA repair in cancer cells, including breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2018 Category: Cancer & Oncology Source Type: news

UC researchers find protein that mediates formation of HER2-driven breast cancer
(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2018 Category: Cancer & Oncology Source Type: news

Scientists identify breast cancer patients who may develop incurable secondary cancers
(King's College London) Scientists from King's College London, funded by Breast Cancer Now, believe they have found a way to identify lymph-node positive breast cancer patients who are most likely to develop incurable secondary tumors (metastases) and those who are less at risk. The research is published on the Jan. 9 in The Journal of Pathology: Clinical Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 9, 2018 Category: International Medicine & Public Health Source Type: news

Working Night Shift May Raise Women's Odds for Cancer
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - January 9, 2018 Category: Cancer & Oncology Source Type: news

Night Shifts Increase Breast Cancer Risk, Especially for Nurses Night Shifts Increase Breast Cancer Risk, Especially for Nurses
A meta-analysis confirms an increased risk for cancer, particularly breast cancer, in women working night shifts. The increase was'remarkable'in night nurses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Athenex gets closer to clinical trials in China
Athenex Inc. (Nasdaq:ATNX) has taken another step forward in its efforts to bring an oral breast cancer drug to market in Asia.   The Buffalo-based biopharmaceutical firm received an acceptance from the Chinese Food& Drug Administration for an investigational new drug (IND) application for Oraxol, an oral version of its oral formulation of the chemotherapy formulation paclitaxel. It’s the next in a series of okays from FDA groups across the world, including the United States, South America,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 8, 2018 Category: Biotechnology Authors: Tracey Drury Source Type: news

Medical News Today: Night shifts raise women's cancer risk
Women who work long-term night shifts may be at increased risk of developing cancer, especially breast cancer, reveals a new study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 8, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news